A correction of misinformation regarding Herbalife

Abstract

The authors of the subject article by Senadhi et al have misrepresented the safety and regulatory status of Herbalife's products. While we are very concerned with the unwarranted and unfavorable publicity that the inaccuracies listed could generate for Herbalife, we would welcome any inquiries that these authors may have to better clarify our commitment to the safety and quality of our products as has been demonstrated in part by our ability to establish positive relationships with regulatory authorities worldwide through continued cooperation and compliance. This letter clarifies the misinformation presented about Herbalife in the subject article.

A critical analysis of the hepatotoxicity cases described in the literature related to Herbalife (r) products

“…Besides these publications, 10 rebuttals from Herbalife® have been published to date in response to the various publications which implicate its brand Appelhans, Frankos, Shao, 2012;Appelhans, Najeeullah, Frankos, 2013a;2014a;2014b;Appelhans, Goldstein, 2011;Ignarro, Heber, Henig, 2008). In summary, these rebuttals express Herbalife's objection to various methodologies which are inappropriately applied and subsequently produced inaccurate conclusions in regard to the review of cases which involve Herbalife's consumers.…”

Deficiencies Identified in Dated Case Reports Associated With Herbalife

“…[1][2][3][4][5][6][7][8][9][10] The authors reference an article by Stickel et al, which implicates Herbalife products in 2 cases of Bacillus subtilis contamination. 11 Of note, Herbalife has previously rebutted these allegations in other publications to highlight critical deficiencies in the methodology used for the isolation of this bacteria from the product samples.…”

“…First and foremost, it should be acknowledged that Herbalife has rebutted the various publications which are cited, none of which are referenced by this author. 1 –10…”